CRT 2015 Valve & Structural - The Role of the TVT Registry: Past, Present and Future

Conference
A session on The Role of the TVT Registry from CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

CRT 2015 Valve & Structural - The Role of the TVT Registry: Past, Present and Future

Session Moderators: Ralph G Brindis, MD; Matthew G. Hillebrenner, MSE

5 Expert Sessions

Featuring

  • Ralph G Brindis, MD 
  • Matthew G. Hillebrenner, MSE
  • Larry L. Wood
  • John C. Laschinger, MD
  • Michael J. Mack, MD
  • Daniel A. Canos, MPH
  • T. Syrek Jensen, JD
  • Chuck A. Simonton, MD
  • Eric Vang, PhD
  • Changfu Wu, PhD

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Post-Marketing Report: Have TAVR Outcomes Improved in the Post-Marketing Phase? Insights from the TVT Registry - Michael J. Mack, MD
Lessons Learned from the TVT Registry Experience - Larry L. Wood
Registries in the Regulatory Paradigm - John C. Laschinger, MD
Looking Forward: Sustainability of TVTR - Michael J. Mack, MD

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons

Session Name: The Role of the TVT Registry: Past, Present and Future

Track: Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Related Moments

CRT 2016 Coronary - The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin
Conference
The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin at CRT 2016
DEFINE-FLAIR & IFR-SWEDEHEART Outcome Data Release International Meeting
Course
A dedicated international meeting discussing the DEFINE FLAIR clinical trial results whilst showing practical use of state-of-art iFR and FFR technology.
Supported By
The Emerging Role Of PCSK9 Inhibitors In Preventive Cardiology
Journal
Article on The Emerging Role Of PCSK9 Inhibitors In Preventive Cardiology
Loading Simple Education